Global Cell and Gene Therapy Cold Chain Logistics Market Report and Forecast 2024-2032

Global Cell and Gene Therapy Cold Chain Logistics Market Outlook

The global cell and gene therapy cold chain logistics market size was valued at USD 1.85 billion in 2023, driven by the increasing adoption of cell and gene therapies and advancements across the globe. The market is anticipated to grow at a CAGR of 15.6% during the forecast period of 2024-2032 to achieve a value of USD 6.81 billion by 2032.

Cell and Gene Therapy Cold Chain Logistics: Introduction

Cell and gene therapies are used to treat diseases and disorders by using living cells and genetic material. Cell and gene therapy are the latest and uniquely designed techniques to treat people with certain medical conditions and disorders. A particular cold chain logistics is required to store and handle all the genetic material that is going to be stored in them.

Global Cell and Gene Therapy Cold Chain Logistics Market Analysis

Packaging logistics are specifically designed to reduce the temperature fluctuations and to maintain the required environment for a long time in terms of temperature. Cryogenic shippers and insulated containers, that provide required temperature control during the process of transportation, are also under development and are likely to aid the global cell and gene therapy cold chain logistics market growth in the coming years.

Additionally, increasing focus on monitoring and data management in order to achieve real-time monitoring systems and data management platforms is also a key trend in the market. This plays an important part in making sure that the integrity of cell and gene therapies is intact.

Global Cell and Gene Therapy Cold Chain Logistics Market Segmentations

Market Breakup by Component

• Cryogenic Shippers

• Cryogenic Storage Freezers

• Ultra Low Freezers

• Cold Chain Management Systems

• Shipment and Storage Medium  

• Cryogenic Packout Kits  

• Others

Market Breakup by Services Offered

• Transportation

• Storage

• Packaging

Market by Mode of Transportation

• Air

• Ground

• Water

Market Breakup by Holding Temperature Range

• Cryogenic

• Refrigerated

• Ambient

• Others

Market Breakup by End User

• Pharmaceutical and Biotechnology Companies

• Academic and Research Institutes

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Cell and Gene Therapy Cold Chain Logistics Market Overview

The growth of the market is primarily driven by the rising adoption of cell and gene therapy cold chain logistics in the healthcare sector. The increasing advancements in regenerative medicine are directly contributing to the efficient cold chain logistics solutions. Another key feature is the rising presence of several key players, who are offering specialized services in cell and gene therapy cold chain logistics. The availability of such services is significantly driving the market growth.

The growth of the market is also driven by the rapid developments by logistics and transportation companies, packaging manufacturers, monitoring and data management solution providers, among others. The market for cell and gene therapy cold chain logistics is an important part of the healthcare industry, which is enabling the safe and efficient delivery of innovative treatments. The global cell and gene therapy cold chain logistics market demand is expected to witness continuous growth and development due to the increasing adoption of these therapies and advancements.

Global Cell and Gene Therapy Cold Chain Logistics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• BioLife Solutions, Inc. 

• United Parcel Service (Marken) 

• AmerisourceBergen Corporation (World Courier) 

• Catalent, Inc. 

• Atelerix Ltd. 

• Cryoport, Inc. 

• Biostor Ltd. 

• Thermo Fisher Scientific Inc. 

• Life Science Group Ltd (LSG) 

• Yourway Biopharma Services Company 

• Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions) 

• Be The Match BioTherapies

Key Highlights of the Report

Cell and Gene Therapy Cold Chain Logistics Market Report Snapshots

Cell and Gene Therapy Cold Chain Logistics Market Size

Cell and Gene Therapy Cold Chain Logistics Market Analysis

Cell and Gene Therapy Cold Chain Logistics Companies